Mohawk Industries
MHK
$102.33
+1.90%
Mohawk Industries is a leading global manufacturer of flooring products, including carpets, rugs, ceramic tile, laminate, wood, and luxury vinyl tile, operating within the Consumer Cyclical sector's furnishings, fixtures, and appliances industry. The company is a dominant player in the flooring market, distinguished by its extensive portfolio of brands and its position as the world's largest producer of ceramic tile, which provides significant scale and distribution advantages. The current investor narrative centers on navigating a cyclical downturn in the housing and remodeling markets, with recent financial results showing significant margin pressure and a sharp decline in profitability, raising questions about the timing of a recovery and the company's ability to manage costs amid weak demand.…
MHK
Mohawk Industries
$102.33
Investment Opinion: Should I buy MHK Today?
Rating: Hold. The core thesis is that while MHK is deeply undervalued and possesses a strong balance sheet, the fundamental deterioration is severe and ongoing, requiring visibility on a cyclical bottom before a Buy rating is warranted.
Supporting evidence includes a forward P/E of 9.75x, which prices in a significant earnings recovery to the analyst consensus of $15.73 EPS. The stock trades at a Price-to-Sales of 0.63x, near historical lows, and a P/B of 0.81x, indicating deep value. However, revenue is sequentially declining, Q4 net margin collapsed to 1.56%, and the stock has underperformed the SPY by 35.60% over three months, reflecting justified pessimism. The balance sheet strength (current ratio 2.19, D/E 0.33) is a positive offset but not a catalyst.
Risks that could invalidate a Hold thesis are: 1) further sequential revenue decline, 2) net margin compression below 1%, or 3) free cash flow turning negative. This Hold would upgrade to a Buy if the forward P/E compresses below 8x without further fundamental deterioration, or if quarterly revenue and margins show sequential stabilization. It would downgrade to a Sell if revenue growth turns negative year-over-year or the 52-week low is breached on high volume. Relative to its own depressed history and the lack of near-term catalysts, the stock is fairly valued for the high level of uncertainty it carries.
Sign up to view all
MHK 12-Month Price Forecast
MHK is a classic deep-value, late-cycle play where the valuation appears to discount a worst-case scenario, but the fundamentals have yet to confirm a bottom. The forward P/E of 9.75x is compelling, but it is a bet on an earnings recovery that recent quarterly results (1.56% net margin) do not support. The strong balance sheet prevents a financial crisis but does not drive growth. The stance would upgrade to Bullish on clear evidence of sequential margin stabilization and revenue inflection, likely requiring another quarter or two of data. It would downgrade to Bearish if the stock breaks below its 52-week low on high volume, signaling a new leg down in the cycle.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Mohawk Industries's 12-month outlook, with a consensus price target around $133.03 and implied upside of +30.0% versus the current price.
Average Target
$133.03
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$82 - $133
Analyst target range
Analyst coverage is limited, with only 3 analysts providing estimates, indicating this is not a widely followed large-cap stock, which can lead to higher volatility and less efficient price discovery. The consensus sentiment appears neutral to cautious, as evidenced by recent institutional actions such as Wolfe Research downgrading from Outperform to Peer Perform in January 2026, while firms like RBC Capital and Wells Fargo maintain equivalent 'Sector Perform' or 'Equal Weight' ratings. The average revenue estimate for the upcoming period is $12.06 billion, with a range from $11.80 billion to $12.24 billion, and the average EPS estimate is $15.73, ranging from $15.28 to $16.03, but without a consensus price target, the implied upside or downside cannot be calculated. The wide range in EPS estimates signals moderate uncertainty about the near-term earnings trajectory, with the high target likely assuming a quicker cyclical recovery and margin restoration, while the low target may be factoring in a prolonged downturn or further cost pressures.
Bulls vs Bears: MHK Investment Factors
The bear case currently holds stronger evidence, grounded in the severe and ongoing deterioration of fundamental profitability and demand. The single most important tension in the investment debate is the timing and magnitude of a cyclical recovery in the housing/remodeling markets versus the risk of a prolonged downturn that could permanently impair earnings power. While the valuation is deeply depressed and the balance sheet is strong, these are not sufficient catalysts without a visible inflection in revenue and margins. The stock appears to be pricing in a significant earnings rebound (forward P/E of 9.75x), but recent quarterly trends provide little confirmation that this rebound is imminent.
Bullish
- Strong Financial Position: The balance sheet is robust with a current ratio of 2.19 and a moderate debt-to-equity ratio of 0.33, providing significant financial flexibility to navigate the downturn. This is further supported by positive TTM free cash flow of $616.2 million, which offers a cushion for operations and potential strategic moves.
- Deeply Oversold & Near 52-Week Low: The stock is trading at $96.56, just 3.2% above its 52-week low of $93.6, after a 27.18% decline over the last three months. This severe technical oversold condition, combined with a forward P/E of 9.75x, suggests most negative news may be priced in, creating a potential value trap exit or rebound opportunity.
- Significant Forward P/E Discount: The forward P/E of 9.75x is nearly half the trailing P/E of 18.35x, indicating the market is pricing in a substantial earnings recovery. Analyst consensus EPS for the next period is $15.73, implying a forward earnings yield over 10%, which is attractive if the cyclical downturn proves temporary.
- Low Valuation Multiples: The stock trades at a Price-to-Sales ratio of 0.63x and an EV/Sales of 0.70x, which are near historical lows for the company. This deep value pricing, coupled with a P/B ratio of 0.81, suggests the market has heavily discounted the stock for the current cyclical weakness.
Bearish
- Severe Profitability Collapse: Q4 2025 net income collapsed to $42 million from $108.9 million in Q3, representing a 61% sequential decline. The net margin compressed to just 1.56% from 3.95%, highlighting intense margin pressure from inflation and an inability to pass on costs.
- Revenue & Demand Deterioration: Revenue is decelerating sequentially, with Q4 2025 revenue of $2.70B down from $2.76B in Q3 and $2.80B in Q2. This clear downtrend, with only 2.37% YoY growth, signals weakening demand across its key housing and remodeling end-markets.
- Persistent Negative Momentum: The stock has underperformed the SPY by 35.60% over the last three months and is down 7.05% in the past month. This persistent negative momentum and high beta of 1.21 indicate continued selling pressure and high volatility, with no technical signs of a bottom yet.
- Cyclical Downturn Headwinds: As a consumer cyclical tied to housing, Mohawk is highly exposed to weak remodeling activity and new construction. Analyst downgrades, like Wolfe Research's move to Peer Perform, reflect a cautious outlook on the timing and strength of a recovery in these key markets.
MHK Technical Analysis
The stock is in a pronounced downtrend, having declined 10.39% over the past year and a severe 27.18% over the last three months, significantly underperforming the broader market. Currently trading at $96.56, the price sits just 3.2% above its 52-week low of $93.6, positioning it near the bottom of its annual range, which suggests the stock is deeply oversold and may present a value opportunity, though it also risks being a 'falling knife' if negative fundamentals persist. Recent momentum remains negative, with the stock down 7.05% over the past month, a continuation of the longer-term downtrend, and its relative strength metrics are deeply negative, showing underperformance of 35.60% against the SPY over the last three months, indicating persistent selling pressure and a lack of bullish catalysts. Key technical support is clearly defined at the 52-week low of $93.6, while resistance lies at the 52-week high of $143.13; a decisive break below support could trigger another leg down, while a recovery would need to overcome significant overhead supply. The stock's beta of 1.21 indicates it is approximately 21% more volatile than the market, which is consistent with its cyclical nature and justifies its heightened price swings during this downturn.
Beta
1.21
1.21x market volatility
Max Drawdown
-32.5%
Largest decline past year
52-Week Range
$93-$143
Price range past year
Annual Return
-0.1%
Cumulative gain past year
| Period | MHK Return | S&P 500 |
|---|---|---|
| 1m | -5.9% | +5.5% |
| 3m | -19.4% | +7.7% |
| 6m | -6.9% | +12.7% |
| 1y | -0.1% | +27.4% |
| ytd | -6.6% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MHK Fundamental Analysis
Revenue growth has stalled and turned negative on a sequential basis, with Q4 2025 revenue of $2.70 billion representing only a 2.37% year-over-year increase, but more critically, it declined from $2.76 billion in Q3 and $2.80 billion in Q2, indicating a clear deceleration. The Global Ceramic segment, which contributed $1.06 billion in the latest period, remains the largest revenue driver, but the overall trend points to weakening demand across the portfolio. Profitability has collapsed dramatically, with Q4 2025 net income plummeting to $42 million from $108.9 million in Q3, and the net margin compressing to just 1.56% from 3.95% the prior quarter. Gross margin of 24.57% in Q4 also contracted from 25.50% in Q2, reflecting inflationary cost pressures and an inability to fully pass them on to customers, severely impacting the bottom line. The balance sheet remains relatively healthy with a strong current ratio of 2.19 and a moderate debt-to-equity ratio of 0.33, providing financial flexibility. However, trailing twelve-month free cash flow of $616.2 million, while positive, is under pressure from the earnings decline, and the Return on Equity of 4.41% is weak, indicating poor returns on shareholder capital in the current environment.
Quarterly Revenue
$2.7B
2025-12
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.24%
Latest Quarter
Free Cash Flow
$616200000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MHK Overvalued?
Given the company remains profitable with positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE is 18.35x, while the forward PE is significantly lower at 9.75x, indicating the market expects a substantial recovery in earnings over the next twelve months. Compared to sector averages, Mohawk's trailing PE of 18.35x is difficult to contextualize without a specific industry average, but its forward multiple suggests the market is pricing in a normalization of profits. The significant discount between trailing and forward multiples highlights the market's anticipation that current depressed earnings are cyclical and not permanent. Historically, the stock's own valuation has compressed sharply; its current price-to-sales ratio of 0.63 is near the lower end of its historical range observed in recent quarters (e.g., 2.49 in Q4 2025), indicating the market has severely de-rated the stock due to the profitability collapse. Trading near historical valuation lows could signal a deep value opportunity if the earnings recovery materializes, but it also reflects justified pessimism given the fundamental deterioration.
PE
18.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -3x~49x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are centered on collapsing profitability and potential cash flow erosion. The Q4 net margin of 1.56% is a severe compression from 3.95% in Q3, driven by gross margin contraction from 25.50% to 24.57%. While free cash flow remains positive at $616M TTM, the 61% sequential decline in net income pressures this metric. The company's dependence on a housing market recovery for revenue growth creates significant earnings volatility, as evidenced by the sharp quarterly declines, and its valuation hinges entirely on a swift earnings normalization that may not materialize.
Market & Competitive Risks include valuation compression and high sensitivity to economic cycles. The stock trades near multi-year lows on P/S (0.63x) and P/B (0.81x) metrics, but further de-rating is possible if the downturn persists longer than expected. With a beta of 1.21, MHK is 21% more volatile than the market, amplifying downside during sector-wide sell-offs. Competitive pressures in the flooring industry could intensify during a downturn, forcing further price concessions and margin erosion. The lack of a broad analyst following (only 3 analysts) contributes to higher volatility and less efficient price discovery.
Worst-Case Scenario involves a prolonged housing recession coupled with sustained inflationary cost pressures, leading to consecutive quarters of net losses. In this scenario, free cash flow could turn negative, forcing the company to leverage its balance sheet. The stock could re-test and break its 52-week low of $93.6, potentially falling to levels implied by a distressed P/S multiple below 0.5x. A realistic downside from the current price of $96.56 could be -35% to the mid-$60s, reflecting a drawdown similar to its recent max drawdown of -32.07%, exacerbated by a broader market downturn.
FAQ
The key risks are, in order of severity: 1) Cyclical Demand Risk: MHK's revenue is tied to the housing and remodeling markets, which are in a downturn, as shown by sequential revenue declines from $2.80B to $2.70B. A prolonged recession is the primary risk. 2) Margin Compression Risk: Gross margin fell from 25.50% to 24.57% in recent quarters, and net margin collapsed to 1.56%, indicating an inability to pass on inflationary costs. 3) Valuation & Sentiment Risk: With a beta of 1.21, the stock is highly volatile and could face further multiple compression if the recovery is delayed. 4) Limited Analyst Coverage Risk: Only 3 analysts follow the stock, which can lead to higher volatility and less liquidity during sell-offs.
The 12-month forecast is bifurcated, with a base case target range of $105-$120 (50% probability), a bull case of $130-$143 (25% probability), and a bear case of $80-$93 (25% probability). The base case, which is most likely, assumes a stabilization of the housing downturn and a modest earnings recovery towards the analyst consensus EPS of $15.73, translating to a forward P/E of approximately 11x. The bull case depends on a swift cyclical rebound and margin restoration, while the bear case involves a deeper recession. The wide range reflects high uncertainty, but the skew is towards the base/bear scenarios until quarterly fundamentals show clear improvement.
MHK appears statistically undervalued based on traditional multiples, but this discount is justified by its deteriorating fundamentals. The forward P/E of 9.75x is low and implies a significant earnings recovery, while the Price-to-Sales ratio of 0.63x and Price-to-Book of 0.81x are near historical lows. Compared to its own history, the stock is cheap. However, valuation must be contextualized with performance: the low multiples reflect a collapse in net margin to 1.56% and declining revenue. The market is pricing in a deep cyclical trough. Therefore, the stock is fairly valued for the high level of uncertainty it carries; it is not cheap enough to ignore the fundamental risks, nor is it expensive given its market leadership.
MHK is a high-risk, high-potential-reward stock that may be a good buy only for specific investors. For deep-value contrarians willing to accept significant volatility (beta 1.21) and wait for a cyclical housing recovery, the current valuation (forward P/E 9.75x, P/S 0.63x) is attractive. However, given the severe fundamental deterioration—Q4 net income fell 61% sequentially—it is not a good buy for growth-oriented or risk-averse investors. The stock's 27% decline over three months suggests pessimism is priced in, but the lack of a visible earnings rebound catalyst warrants caution. It could be a good buy on further weakness below $95 for patient investors, but not at current levels without evidence of a bottom.
MHK is unsuitable for short-term trading due to its high volatility (beta 1.21), negative momentum, and lack of near-term catalysts. It is a long-term, cyclical recovery play that requires a minimum investment horizon of 18-24 months to allow for the housing cycle to potentially trough and rebound. The stock does not pay a dividend, eliminating income as a reason to hold. Given the deep value characteristics and need for fundamental inflection, it is best suited for patient, long-term value investors who can tolerate further downside volatility while waiting for the cycle to turn. A short-term horizon would be purely speculative on technical bounces from oversold levels.